Stay updated on Nivolumab and Axitinib in RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Axitinib in RCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a small update to the page's revision metadata.
    Difference
    0.1%
    Check dated 2026-06-05T13:00:05.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Update timestamps have been added to the study record, showing when the record was last modified and future milestones. These are administrative milestones in the record history and do not change the study content.
    Difference
    0.3%
    Check dated 2026-05-29T09:32:39.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays revision v3.5.4 instead of v3.5.3, indicating an updated version of the page template or documentation.
    Difference
    0.1%
    Check dated 2026-05-15T07:49:29.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page revision/version label has been updated from v3.5.2 to v3.5.3, indicating a platform release rather than a change to the clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:23:55.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:13:15.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    A new revision label v3.5.0 was added and the previous label v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:39:58.000Z thumbnail image

Stay in the know with updates to Nivolumab and Axitinib in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.